Early detection of hepatitis B drug resistance: implications for patient management.

Abstract excerpt

Despite the availability of safe and effective prophylactic vaccines, hepatitis B viral disease has remained a tenacious scourge, ranking ninth globally among all causes of mortality (up to 1 million deaths annually). Approximately 6% of the global population--more than 350 million people--have failed to resolve viral infection and become chronic carriers, eventually placing between 15 and 25% of such individuals...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenine
• Share to Antiviral Agents
• Share to Drug Resistance, Viral